783 Evaluating the Impact of High-Dose Steroids on Checkpoint Inhibitor Efficacy in a Murine Model of Melanoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.859
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dose-Response Relationship of Ultrasound Contrast Agent in an in Vivo Murine Melanoma Model

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2007English

Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model

PLoS ONE
Multidisciplinary
2013English

In Vivo Depletion of CD25+ Cells Prior to LRAST Increases Therapeutic Efficacy in a Murine Melanoma Model

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

A Murine Model for Metastatic Conjunctival Melanoma

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Dose Efficacy Study of Two Schedules of High-Dose Bolus Administration of Interleukin 2 and Interferon Alpha in Metastatic Melanoma

British Journal of Cancer
Cancer ResearchOncology
1996English

High Mortality and Poor Treatment Efficacy of Immune Checkpoint Inhibitors in Patients With Severe Grade Checkpoint Inhibitor Pneumonitis in Non‐small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Efficacy of Ambruticin Analogs in a Murine Model of Coccidioidomycosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Evaluating the Impact of a Tetravalent Vaccine in Populations With High-Incidence of Dengue: A Mathematical Model

Nonlinear Analysis and Differential Equations
2016English

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy